Related Experiment Video
Updated: Jun 14, 2025

A Method for Measuring RNA N6-methyladenosine Modifications in Cells and Tissues
Published on: December 5, 2016
Insights into RNA N6-methyladenosine and programmed cell death in atherosclerosis
Haijiao Long1,2, Yulu Yu3, Jie Ouyang1,2
1Health Management Center, The Third Xiangya Hospital of Central South University, Changsha, 410013, China.
Abstract:
N6-methyladenosine (m6A) modification stands out among various RNA modifications as the predominant form within eukaryotic cells, influencing numerous cellular processes implicated in disease development. m6A modification has gained increasing attention in the development of atherosclerosis and has become a research hotspot in recent years. Programmed cell death (PCD), encompassing apoptosis, autophagy, pyroptosis, ferroptosis, and necroptosis, plays a pivotal role in atherosclerosis pathogenesis. In this review, we delve into the intricate interplay between m6A modification and diverse PCD pathways, shedding light on their complex association during the onset and progression of atherosclerosis. Clarifying the relationship between m6A and PCD in atherosclerosis is of great significance to provide novel strategies for cardiovascular disease treatment.
Related Concept Videos
RNA Stability
RNA Editing
Nuclear Export of mRNA
Experimental RNAi
Nonsense-mediated mRNA Decay
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
mRNA Stability and Gene Expression
Cis-acting Elements involved in mRNA stability

